Hello. Sign in to personalize your visit. New user? Register now.  
Rejuvenation Research
Aging, Stem Cells, and Mammalian Target of Rapamycin: A Prospect of Pharmacologic Rejuvenation of Aging Stem Cells

To cite this article:
Mikhail V. Blagosklonny. Rejuvenation Research. August 2008, 11(4): 801-808. doi:10.1089/rej.2008.0722.

Published in Volume: 11 Issue 4: August 27, 2008

Full Text: • PDF for printing (281.2 KB) • PDF w/ links (164 KB)


Mikhail V. Blagosklonny
Ordway Research Institute, Cancer Center, Albany, New York.
Oncotarget, Albany, New York.

Abstract

What is the relationship between stem cell aging and organismal aging? Does stem cell aging cause organismal aging or vice versa? Will stem cell aging aggravate age-related diseases? And what is stem cell aging? As suggested herein, hyperstimulation of signal transduction pathways can render cells compensatorily irresponsive. And the hallmark of stem cell aging is poor responsiveness to activating stimuli. On the basis of the hypothesis that insensitivity to stimuli is in part due to hyperactivation of the target of rapamycin (TOR), this article suggests a means of pharmacologic rejuvenation of stem cells and wound-healing cells.

Free first page

This paper was cited by:

Commentary on Some Recent Theses Relevant to Combating Aging
Aubrey D.N.J. de Grey
Rejuvenation Research. Apr 2009, Vol. 12, No. 2: 149-154
First Page | Full Text PDF | Reprints & Permissions
Commentary on Some Recent Theses Relevant to Combating Aging
Aubrey D.N.J. de Grey
Rejuvenation Research. Feb 2009, Vol. 12, No. 1: 53-58
First Page | Full Text PDF | Reprints & Permissions
All articles
Previous Next